Clinical Trials Browser

Active not recruiting × Recurrence × Immunotherapy, Adoptive × Clear all

NCT03919240 2024-10-24

CAR-T Cell Therapy Targeting to CD19 for R/R ALL

Phase 1/2 Active not recruiting

LymphoidOther hematologic neoplasm

Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma